Jennifer Fillman, MBA

Research Reports

Community Oncologists‚ Perception and Adaptability to Emerging Chimeric Antigen T-Cell Therapy

10/16/2017

Chadi Nabhan, MD, MBA, FACP

Yolaine Jeune-Smith, PhD

Peter Klinefelter, BA

Jennifer Fillman, MBA

Bruce A. Feinberg, DO

Abstract: The Oncologic Drugs Advisory Committee recently voted 10-0 recommending to the Food and Drug Administration (FDA) the approval of the first chimeric antigen receptor T (CAR-T) therapy. We sought to better...

...

10/16/2017

Journal of Clinical Pathways

Counterpoint

The Pivot Toward Patient-Centeredness in Medicine and Oncology

09/06/2016

Bruce Feinberg, DO

Julia Braverman, PhD

Jennifer Fillman, MBA

Patient-reported outcome (PRO) research has shown that PROs must play a role in the future of health care delivery as the system transitions from volume-based care to value-based care. Building trust among...

...

09/06/2016

Journal of Clinical Pathways